Cumberland Pharmaceuticals Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +3.3% | +6.1% | -10.1% | +29.2% | +4.0% | -26.3% | +18.4% | -16.4% | +58.9% | -11.8% | -2.7% | -10.4% | +31.9% | -39.1% | +15.2% | -3.6% | +10.9% | +2.7% | -14.1% | -10.9% | +3.1% | +34.3% | -7.8% | +10.8% | -20.1% | +1.1% | +18.0% | -7.4% | -7.3% | -9.1% | +15.9% | -7.7% | +14.9% | +12.2% | -7.5% | -23.5% | +65.0% | -33.2% | -98.2% | – | |
| – | -18.7% | -14.0% | +20.8% | +29.8% | -0.6% | -29.1% | -0.3% | -4.1% | +96.3% | -30.2% | +0.6% | -4.5% | +46.6% | -42.0% | +59.7% | -17.9% | +5.7% | +6.7% | -28.0% | -23.7% | +150.4% | -33.5% | -8.1% | +9.5% | +19.1% | -52.8% | +21.6% | +16.1% | -13.3% | +3.0% | +8.6% | -22.7% | +49.4% | -27.9% | +41.1% | -50.8% | +126.7% | -13.7% | -98.1% | – | |
| – | +9.7% | +10.4% | -15.2% | +29.0% | +5.1% | -25.7% | +22.4% | -18.6% | +51.2% | -6.9% | -3.4% | -11.7% | +28.5% | -38.3% | +4.4% | +1.7% | +12.5% | +1.6% | -9.9% | -7.8% | -25.9% | +79.5% | -7.8% | +11.1% | -29.6% | +23.2% | +17.5% | -11.2% | -6.0% | -11.5% | +17.6% | -4.6% | +9.0% | +21.6% | -14.2% | -17.2% | +56.6% | -37.1% | -98.2% | – | |
| – | +80.1% | -22.6% | +20.3% | -12.7% | +3.8% | +91.4% | -22.6% | -10.0% | +105.9% | -52.9% | +15.0% | -12.4% | +93.6% | -30.4% | -17.5% | -13.4% | +13.7% | -10.2% | +8.2% | +6.9% | +10.9% | +8.2% | +4.5% | -6.0% | -18.0% | +6.7% | -23.6% | +68.1% | -34.3% | -8.4% | -8.6% | +23.3% | -1.0% | +0.2% | +13.4% | -14.6% | +23.6% | -5.9% | -47.1% | – | |
| – | +47.1% | -23.1% | +11.5% | -11.1% | +66.3% | -33.0% | +0.2% | -11.4% | +77.6% | -27.3% | -5.3% | -4.2% | +13.1% | -25.7% | +7.6% | +8.7% | +50.7% | -37.8% | -6.0% | -2.7% | +67.3% | -32.5% | -4.3% | -1.7% | +61.9% | -28.8% | -5.2% | -1.1% | +46.7% | -31.1% | +16.4% | -3.0% | +24.3% | -26.0% | +16.7% | -10.5% | +57.0% | -36.7% | -0.3% | – | |
| – | +26.1% | +5.7% | -2.6% | +13.7% | +5.4% | -8.5% | 0.0% | -7.1% | +45.9% | -21.8% | +0.9% | +1.2% | +15.2% | -28.0% | +0.3% | -2.9% | +17.1% | -13.3% | +3.6% | -5.1% | +12.5% | +9.7% | -1.4% | -6.3% | -7.7% | +8.6% | -1.7% | +9.0% | +37.5% | -37.2% | +4.2% | +3.2% | +8.9% | -12.7% | +6.4% | -3.2% | +38.2% | -19.4% | -68.1% | – | |
| – | -835.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -8,265.7% | – | – | – | – | – | – | -157.9% | – | – | – | – | – | |
| – | -1.6% | +10.8% | -5.3% | -70.4% | +150.0% | -17.8% | +20.3% | -12.8% | +610.1% | -55.3% | +49.7% | -28.9% | -55.0% | +13.2% | +261.3% | -37.0% | -52.3% | -32.0% | +5.9% | -22.6% | +38.5% | +331.1% | +15.1% | +8.5% | +20.2% | +3.8% | +3.4% | -42.9% | +62.4% | -33.7% | +6.6% | +8.7% | +62.5% | -26.6% | -33.1% | +0.1% | +3.0% | -24.0% | -99.2% | – | |
| – | -716.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -315.3% | – | – | – | – | – | – | +384.9% | -221.5% | – | – | – | – | – | – | -158.2% | – | – | – | – | – | |
| – | -400.1% | – | +438.5% | -99.9% | -657.4% | – | +0.0% | +0.0% | +0.0% | -2,057.9% | – | +0.0% | -252.7% | – | -78.2% | -50.0% | +181.1% | -28.8% | +0.0% | 0.0% | +67.8% | -44.9% | +0.0% | +0.0% | +597.8% | -85.6% | 0.0% | +0.0% | +259.7% | -54.2% | +0.0% | 0.0% | -598.1% | – | +0.0% | 0.0% | +310.0% | -83.3% | 0.0% | – | |
| – | -806.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +636.4% | -185.9% | – | – | – | – | – | – | +353.8% | -220.3% | – | – | – | – | – | – | -158.9% | – | – | – | – | – | |
| – | -137.9% | – | -1,805.1% | – | – | – | – | – | – | – | -38.2% | -433.6% | – | -478.9% | – | – | – | – | +118.5% | -124.3% | – | – | +5.4% | +220.8% | -234.7% | – | +42.7% | -78.9% | -845.6% | – | – | -97.2% | +253.6% | +5,817.8% | -74.4% | -173.0% | – | -3,213.9% | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.